ovarian cancer

Ovarian Cancer Advances Summit (OVAS) 2021

A multi-disciplinary approach to managing patients with Ovarian Cancer. OVAS 2021 will be hosted by an independent steering committee, featuring ANZGOG members, and an international speaker panel. The summit will be delivered via online webinars and meetings held in [...]

Ovarian Cancer Advances Summit (OVAS) 20212021-11-22T22:35:19+11:00

National Carer’s Week – Meet the caregivers of Survivors Teaching Students

During National Carers Week, ANZGOG recognises and thanks the caregivers who bravely share their very personal stories with students across Australia and New Zealand as part of the Survivors Teaching Students® (STS) program. Survivors [...]

National Carer’s Week – Meet the caregivers of Survivors Teaching Students2021-10-13T03:06:18+11:00

ANZGOG’s Preceptorship in Ovarian Cancer 2021

As part of their Education Series for Fellows, Trainees, Registrars, and early career clinicians, ANZGOG is conducting a Virtual Ovarian Cancer Preceptorship. The Preceptorship in Ovarian Cancer 2021 learning objectives are: To learn about best clinical practice in the [...]

ANZGOG’s Preceptorship in Ovarian Cancer 20212021-11-25T02:21:10+11:00

Exploring aspirin as an ovarian cancer preventative for women with BRCA 1/2 mutations

STICs and STONEs is a randomised, Phase II, double-blind, placebo-controlled trial of aspirin in the prevention of ovarian cancer in women with BRCA1 and BRCA2 mutations. Prof Phillips, Principal Investigator of STICs and STONEs, [...]

Exploring aspirin as an ovarian cancer preventative for women with BRCA 1/2 mutations2021-09-28T03:53:44+10:00

Dr Rachel Campbell discusses findings from a new publication for the MOST-S26 study

A new journal has been published by the National Library of Medicine for ANZGOG's MOST-S26 study. The Measure of Ovarian Symptoms and Treatment study (MOST-S26) detected an improvement in symptoms of peripheral neuropathy, psychological [...]

Dr Rachel Campbell discusses findings from a new publication for the MOST-S26 study2021-09-15T00:55:56+10:00
Go to Top